Nanotechnology and cancer

K. Meena Kumari, M. C. Satish Kumar, B. R. Eesha, Amberkar Mohanbabu Vittalrao, K. L. Bairy, A. L. Udupa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Clinical medicine has seen tremendous improvements during past several decades. Despite its progress in many illnesses till date, cancer is not detected at the earliest subclinical stages. Patients still are exposed to highly toxic whole body chemotherapy. However with the discovery of nanotechnology which has emerged as a new tool for early diagnosis and as a targeted drug delivery system to the cancer cells will prevent mortality and increase the quality of life in cancer patients. Though extensive research is being done for various diseases like autoimmune, inflammatory and metabolic disorders, in this review we have stressed on the usage of various nanotechnological tools and methods in cancer detection and treatment. However like any novel technology, this also has some safety and ethical issues which have been discussed in this review.

Original languageEnglish
Pages (from-to)267-276
Number of pages10
JournalPharmacologyonline
Volume2
Publication statusPublished - 01-01-2010

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Nanotechnology and cancer'. Together they form a unique fingerprint.

  • Cite this

    Meena Kumari, K., Satish Kumar, M. C., Eesha, B. R., Vittalrao, A. M., Bairy, K. L., & Udupa, A. L. (2010). Nanotechnology and cancer. Pharmacologyonline, 2, 267-276.